SINGAPORE (Aug 26): OCBC Investment Research has maintained its “hold” recommendation for Raffles Medical Group with a fair value of $1.54, after taking into account the near-term cost pressures seen in its 2Q results.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply